Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Low molecular weight heparin.

× No keyword cloud information.

98 in total

1. Enhancing Thrombolysis with Adjunctive Therapy.

Authors:
Journal: J Thromb Thrombolysis Date: 1996 Impact factor: 2.300

2. Low-Molecular-Weight Heparin Should Replace Unfractionated Heparin for Treatment of Venous Thrombosis and Unstable Angina.

Authors:
Journal: J Thromb Thrombolysis Date: 1997 Impact factor: 2.300

Review 3. The role of low-molecular-weight heparins in the management of unstable angina and non-ST-segment elevation myocardial infarction.

Authors: M Cohen
Journal: J Thromb Thrombolysis Date: 2001-04 Impact factor: 2.300

Review 4. How We Manage Pediatric Deep Venous Thrombosis.

Authors: Marisol Betensky; Mark A Bittles; Paul Colombani; Neil A Goldenberg
Journal: Semin Intervent Radiol Date: 2017-03 Impact factor: 1.513

5. Quantitative capillary electrophoresis determination of oversulfated chondroitin sulfate as a contaminant in heparin preparations.

Authors: Nicola Volpi; Francesca Maccari; Robert J Linhardt
Journal: Anal Biochem Date: 2009-02-14 Impact factor: 3.365

Review 6. Measuring anti-factor xa activity to monitor low-molecular-weight heparin in obesity: a critical review.

Authors: Gregory Egan; Mary H H Ensom
Journal: Can J Hosp Pharm Date: 2015 Jan-Feb

7. Clinical Feasibility of Monitoring Enoxaparin Anti-Xa Concentrations: Are We Getting It Right?

Authors: Wesley D Kufel; Robert W Seabury; William Darko; Luke A Probst; Christopher D Miller
Journal: Hosp Pharm Date: 2017-03

8. Dosing strategy for enoxaparin in patients with renal impairment presenting with acute coronary syndromes.

Authors: B Green; M Greenwood; D Saltissi; J Westhuyzen; L Kluver; J Rowell; J Atherton
Journal: Br J Clin Pharmacol Date: 2005-03 Impact factor: 4.335

Review 9. Novel antithrombotic drugs in development.

Authors: M Verstraete; P Zoldhelyi
Journal: Drugs Date: 1995-06 Impact factor: 9.546

Review 10. Drug treatment associated with heart valve replacement.

Authors: D S Coulshed; M A Fitzpatrick; C H Lee
Journal: Drugs Date: 1995-06 Impact factor: 9.546